Paradigm Spine
Innovative spinal implants enhancing stability and motion with advanced titanium technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
$14.0m | Series C | ||
| Total Funding | 000k | ||
Paradigm Spine specializes in developing and marketing advanced spinal implants designed to improve patient outcomes by enhancing stability and motion. The company's core product line includes the DCI implant, which acts as a shock absorber to prevent accelerated degeneration in adjacent spinal segments, and the Fortilink TC interbody fusion devices, which are built from implant-grade titanium alloy using Selective Laser Melting (SLM) technology. These devices feature optimized pore shapes and sizes for bony ingrowth, excellent radiographic visualization, and a modulus of elasticity similar to cancellous bone, making them highly effective for spinal fusion procedures.
Paradigm Spine serves healthcare providers, including hospitals and surgical centers, operating in the spinal surgery market. The business model revolves around the sale of these specialized implants, which are delivered sterile-packed and ready for use in surgical procedures. Revenue is generated through direct sales to medical institutions and partnerships with distributors.
Keywords: spinal implants, stability, motion, titanium technology, DCI implant, Fortilink TC, spinal fusion, healthcare providers, surgical centers, Selective Laser Melting.